SQZ Biotechnologies (SQZ) News Today $0.02 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period What is the price tag to keep the biotech engine humming in Massachusetts?July 23, 2024 | msn.comSQZ Biotechnologies Company (SQZB)May 22, 2024 | finance.yahoo.comSqz Bio (SQZB) Earnings Dates & ReportsMay 8, 2024 | investing.comVC funding update: who raised money in March?April 1, 2024 | bizjournals.comPortal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VCMarch 19, 2024 | finance.yahoo.comSQZB SQZ Biotechnologies CompanyDecember 28, 2023 | seekingalpha.comSQZ Biotechnologies Co Ordinary Shares SQZBDecember 12, 2023 | morningstar.comSQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio UpdatesNovember 8, 2023 | finance.yahoo.comSQZ Biotechnologies GAAP EPS of -$0.80 misses by $0.30, revenue of $0MNovember 8, 2023 | msn.comLifeline Biotechnologies Inc LLBONovember 4, 2023 | morningstar.comSQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual MeetingNovember 3, 2023 | finance.yahoo.comSQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio UpdatesAugust 10, 2023 | finance.yahoo.comSqz Biotechnologies Co (SQZB)August 3, 2023 | investing.comSQZ Biotechnologies Provides Update on Collaboration with RocheJuly 25, 2023 | benzinga.comSQZ Biotechnologies to be delisted from the NYSEJuly 3, 2023 | seekingalpha.comNYSE to Commence Delisting Proceedings Against SQZ Biotechnologies Company (SQZ)July 3, 2023 | finance.yahoo.comTrading was temporarily halted for "SQZ" at 01:07 PM with a stated reason of "News pending."July 3, 2023 | marketbeat.comSQZ Biotechnologies to Consolidate Shares with 1-for-10 Reverse Stock SplitJune 15, 2023 | finance.yahoo.comH.C. Wainwright Reaffirms Their Hold Rating on SQZ Biotechnologies (SQZ)May 11, 2023 | markets.businessinsider.comSQZ Biotechnologies Reports First Quarter 2023 Financial Results and Recent Portfolio UpdatesMay 10, 2023 | finance.yahoo.comSQZ Biotechnologies Company (SQZ) Reports Q1 Loss, Misses Revenue EstimatesMay 10, 2023 | finance.yahoo.comInvestors Aren't Entirely Convinced By SQZ Biotechnologies Company's (NYSE:SQZ) RevenuesApril 17, 2023 | finance.yahoo.comSQZ Biotechnologies's Return On Capital Employed InsightsMarch 29, 2023 | msn.comShort Volatility Alert: Sqz BiotechnologiesMarch 24, 2023 | benzinga.comBTIG Remains a Buy on SQZ Biotechnologies (SQZ)March 24, 2023 | markets.businessinsider.comSQZ Biotech's Cancer Candidate Shows Response At Low Dose In HPV16+ Solid Tumor PatientMarch 23, 2023 | finance.yahoo.comStocks to Watch: Coinbase, Agile Therapeutics, Steelcase, SQZ BiotechnologiesMarch 22, 2023 | marketwatch.comSQZ Biotechnologies Shares Advance 44% on Continued AAC TrialMarch 22, 2023 | marketwatch.comSQZ Biotechnologies Stock Jumps 40% On Confirmed Complete Response HPV16+ Solid Tumor PatientMarch 22, 2023 | markets.businessinsider.comSQZ Biotechnologies Reports Full Year 2022 Financial Results and Recent Portfolio UpdatesMarch 22, 2023 | finance.yahoo.comSQZ Biotechnologies Announces Confirmed Complete Response in HPV16+ Solid Tumor Patient in the Lowest-Dose Cohort of the SQZ-AAC-HPV-101 Clinical TrialMarch 22, 2023 | finance.yahoo.comSQZ Biotechnologies gets non-compliance notice from NYSEJanuary 19, 2023 | msn.comSQZ Biotechnologies Receives Notice Regarding Continued Listing Standards From the New York Stock ExchangeJanuary 18, 2023 | finance.yahoo.comSQZ Biotechnologies's Return On Capital Employed OverviewDecember 16, 2022 | benzinga.comSQZ Biotechnologies Receives FDA Fast Track Designation for its eAPC Therapeutic Candidate for Treatment of HPV16+ Tumors and Presents Clinical Data for Multiple Programs at the European Society for Medical Oncology Immuno-Oncology CongressDecember 6, 2022 | finance.yahoo.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SQZ Biotechnologies Company - SQZDecember 1, 2022 | benzinga.comAnalyst Ratings for SQZ BiotechnologiesDecember 1, 2022 | markets.businessinsider.comExpert Ratings for SQZ BiotechnologiesDecember 1, 2022 | markets.businessinsider.comSQZ Biotech CEO steps down amid 60% workforce reduction, pause on some clinical programsDecember 1, 2022 | seekingalpha.comRoche-partnered cell therapy company lays off most of its staff, loses CEO, CFODecember 1, 2022 | finance.yahoo.comSQZ Biotechnologies Announces Strategic Prioritization of SQZ® Enhanced Antigen Presenting Cells Program; Armon Sharei to Step Down as Chief Executive OfficerNovember 30, 2022 | finance.yahoo.comSQZ Biotechnologies Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues LagNovember 12, 2022 | finance.yahoo.comSQZ Biotechnologies Presents Cell Squeeze® Manufacturing Platform, Linked Antigen mRNA Preclinical Research, and COMMANDER-001 Phase 1/2 Clinical Trial in Progress Poster at Society for Immunotherapy of Cancer Annual MeetingNovember 10, 2022 | finance.yahoo.comSQZ Biotechnologies Reports Third Quarter 2022 Financial Results and Recent Portfolio UpdatesNovember 9, 2022 | finance.yahoo.comMultiple insiders bought SQZ Biotechnologies Company (NYSE:SQZ) stock earlier this year, a positive sign for shareholdersNovember 8, 2022 | finance.yahoo.comSQZ Biotechnologies Publishes Preclinical Research Demonstrating SQZ® AAC Platform's Potential as an Effective Red Blood Cell-Derived ImmunotherapyOctober 3, 2022 | benzinga.comSQZ Biotechnologies Publishes Preclinical Research Demonstrating SQZ® AAC Platform’s Potential as an Effective Red Blood Cell-Derived ImmunotherapyOctober 3, 2022 | finance.yahoo.comIs SQZ Biotechnologies (NYSE:SQZ) In A Good Position To Invest In Growth?September 26, 2022 | nasdaq.comSQZ Biotechnologies Presents Preclinical SQZ® TIL Data Supporting Potential Ability of mRNA-Driven IL-2 and IL-12 Expression to Eliminate Need for Toxic Preconditioning and Systemic IL-2 Administration for Certain T Cell TherapiesSeptember 12, 2022 | finance.yahoo.comSQZ Biotechnologies Announces Leadership TransitionSeptember 6, 2022 | finance.yahoo.com Get SQZ Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SQZ and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here SQZ Media Mentions By Week SQZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SQZ News Sentiment▼0.000.44▲Average Medical News Sentiment SQZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SQZ Articles This Week▼00▲SQZ Articles Average Week Get SQZ Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SQZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies USDP News Today CISS News Today RA News Today CMBT News Today FLNG News Today IMPPP News Today PXSAP News Today TRMD News Today ENB News Today CP News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:SQZ) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SQZ Biotechnologies Please log in to your account or sign up in order to add this asset to your watchlist. Share SQZ Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.